CD33 and acute myeloid leukemia: CAR‐DC and CAR‐T cells enhances cytotoxic cytokine production in response to DC‐derived IL‐12. These combined effects resulted in improved anti‐CD33 CAR‐T cytotoxicity in vitro and in vivo NSG AML mice model.